Literature DB >> 9503031

Human recombinant alpha 2-HS glycoprotein is produced in insect cells as a full length inhibitor of the insulin receptor tyrosine kinase.

L Kalabay1, K Chavin, J P Lebreton, K A Robinson, M G Buse, P Arnaud.   

Abstract

Human Alpha 2-HS glycoprotein (AHSG), a glycoprotein synthesized by hepatocytes, was expressed in insect cells using the recombinant baculovirus system. The protein was purified from the cell supernatant, and appeared as a single band at about 52 kDa. Western blot using a specific antibody to the B-chain of AHSG indicated that the connecting peptide was present in the protein. When incubated with solubilized insulin receptors, recombinant AHSG inhibited the tyrosine kinase activity of the receptors in a dose-dependent fashion at concentrations in the range of those of the circulating protein. AHSG did not interfere with the binding of insulin to its receptor. These results indicate that human AHSG represents a natural inhibitor of the insulin receptor tyrosine kinase, is active as a single-chain protein and possesses a biological role similar to that of its homologue in rats, pp63, described by Auberger et al. (1).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9503031     DOI: 10.1055/s-2007-978822

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  10 in total

1.  Phosphorylation of human plasma alpha2-Heremans-Schmid glycoprotein (human fetuin) in vivo.

Authors:  A C Haglund ; B Ek; P Ek
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

2.  Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study.

Authors:  Joachim H Ix; Michael G Shlipak; Vincent M Brandenburg; Sadia Ali; Markus Ketteler; Mary A Whooley
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

3.  Fetuin-A, adiposity-linked insulin resistance and responsiveness to an educational-based weight excess reduction program: a population-based survey in prepubertal schoolchildren.

Authors:  Giuseppe Murdolo; Cristina Tortoioli; Federica Celi; Vittorio Bini; Francesco Papi; Annalisa Brozzetti; Alberto Falorni
Journal:  Endocrine       Date:  2016-07-07       Impact factor: 3.633

4.  Fetuin-A and change in body composition in older persons.

Authors:  Joachim H Ix; Christina L Wassel; Glenn M Chertow; Annemarie Koster; Karen C Johnson; Frances A Tylavsky; Jane A Cauley; Steven R Cummings; Tamara B Harris; Michael G Shlipak
Journal:  J Clin Endocrinol Metab       Date:  2009-10-09       Impact factor: 5.958

Review 5.  Inflammation Markers in Type 2 Diabetes and the Metabolic Syndrome in the Pediatric Population.

Authors:  Thomas Reinehr; Christian Ludwig Roth
Journal:  Curr Diab Rep       Date:  2018-10-18       Impact factor: 4.810

6.  Human Fetuin-A Rs4918 Polymorphism and its Association with Obesity in Healthy Persons and in Patients with Myocardial Infarction in Two Hungarian Cohorts.

Authors:  György Temesszentandrási; Krisztián Vörös; Bernadett Márkus; Zoltán Böröcz; Edit Kaszás; Zoltán Prohászka; András Falus; Károly Cseh; László Kalabay
Journal:  Med Sci Monit       Date:  2016-08-04

7.  Fetuin-A as an Alternative Marker for Insulin Resistance and Cardiovascular Risk in Prepubertal Children.

Authors:  Young Suk Shim; Min Jae Kang; Yeon Jeong Oh; Joon Woo Baek; Seung Yang; Il Tae Hwang
Journal:  J Atheroscler Thromb       Date:  2017-02-01       Impact factor: 4.928

8.  Fetuin-A levels in obesity: differences in relation to metabolic syndrome and correlation with clinical and laboratory variables.

Authors:  Nagwa Abdallah Ismail; Shadia Ragab; Soha M Abd El Dayem; Abeer Abd Elbaky; Nehal Salah; Mona Hamed; Heba Assal; Hala Koura
Journal:  Arch Med Sci       Date:  2012-11-07       Impact factor: 3.318

9.  Human serum fetuin A/alpha2HS-glycoprotein level is associated with long-term survival in patients with alcoholic liver cirrhosis, comparison with the Child-Pugh and MELD scores.

Authors:  László Kalabay; László Gráf; Krisztián Vörös; László Jakab; Zsuzsa Benko; László Telegdy; Béla Fekete; Zoltán Prohászka; George Füst
Journal:  BMC Gastroenterol       Date:  2007-03-29       Impact factor: 3.067

Review 10.  Metabolic Syndrome: Updates on Pathophysiology and Management in 2021.

Authors:  Gracia Fahed; Laurence Aoun; Morgan Bou Zerdan; Sabine Allam; Maroun Bou Zerdan; Youssef Bouferraa; Hazem I Assi
Journal:  Int J Mol Sci       Date:  2022-01-12       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.